Building consensus on the application of organoid-based drug sensitivity testing in cancer precision medicine and drug developmentDongxi Xiang, Yingbin Liu, Aina He et al.|Theranostics|2024Cited by 88
Role of MUC20 overexpression as a predictor of recurrence and poor outcome in colorectal cancerXiuying Xiao, Xiang Du|Journal of Translational Medicine|2013Cited by 58
Interplay between gut microbial communities and metabolites modulates pan-cancer immunotherapy responsesXiaoqiang Zhu, Haoyan Chen, Muni Hu et al.|Cell Metabolism|2025Cited by 56
CLDN18.2–targeting antibody–drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trialJia Liu, Lin Shen, Yueyin Pan et al.|Nature Medicine|2025Cited by 29
Coordinated silencing of the Sp1-mediated long noncoding RNA MEG3 by EZH2 and HDAC3 as a prognostic factor in pancreatic ductal adenocarcinomaTing Han, Meng Zhuo, Cuncun Yuan et al.|Cancer Biology and Medicine|2020Cited by 24